Androgen receptor antagonist suppresses exercise-induced hypertrophy of skeletal muscle
The physiological importance of the increase in androgen receptors in exercise-induced muscle hypertrophy was investigated in rats. Together with training rat gastrocnemius muscles by electrical stimulation every other day for 2 weeks, male rats were administered the androgen receptor antagonist, oxendolone. The androgen receptor antagonist effectively decreased the wet mass of the prostate, an androgen target organ, and did not significantly affect body mass. The increase in muscle mass induced by electrical stimulation was effectively suppressed by the androgen receptor blockade. The mean degree of muscle hypertrophy in the antagonist-treated group was significantly lower than that in the control group (102.30% vs 107.41%, respectively;P=0.006). This result suggests that the androgen pathway has a significant effect in exercise-induced muscle hypertrophy and emphasizes the importance of the increase in the number of androgen receptors in exercised muscle.
Key wordsExercise Androgen receptor Androgen receptor antagonist Skeletal muscle Muscle hypertrophy
Unable to display preview. Download preview PDF.
- Inoue K, Yamasaki S, Fushiki T, Kano T, Moritani T, Itoh K, Sugimoto E (1993) Rapid increase in the number of androgen receptors following electrical stimulation of the rat muscle. Eur J Appl Physiol 66:134–140Google Scholar
- Sudo K, Yamazaki I, Masuoka M, Nakayama R (1979a) Antiandrogen TSAA-291. IV. Effects of the anti androgen TSAA291 (16beta-ethyl-17-beta-hydroxy-4-oestren-3-one) on the secretion of gonadotrophins. Acta Endocrinol 92 [Suppl 229]:53–66Google Scholar
- Sudo K, Yoshida K, Nakayama R (1979b) Anti-androgen TSAA291: VI. Effects of the anti-androgen TSAA-291 and its related compounds on the in vitro formation of 5alpha-DHTreceptor complex in the cytosol of rat ventral prostates. Acta Endocrinol 92 [Suppl 229]:82–99Google Scholar
- Tremblay RR, Dubé JY, Ho-Kim MA, Lesage R (1977) Determination of rat muscle androgen-receptor complexes with methyltrienolone. Steroids 219:185–195Google Scholar